The EyeBOX device’s unique data collection capability is used in a proprietary algorithm that generates a BOX Score, an assessment which the FDA has authorized as an aid in the diagnosis of concussion, or mTBI. Each analysis is unique to each patient.
Research is ongoing in a number of areas important in concussion. EyeBOX technology may be useful for identifying those at risk for second impact syndrome (SIS), a rare but serious condition in which a second concussion occurs before a first concussion has properly healed, causing rapid and severe brain swelling.
The BOX Score may also enable healthcare providers to rule out concussion in cases such as neck injury or inner ear damage that have symptoms common to concussion, such as dizziness, headache and nausea.
The EyeBOX test requires no pre-test calibration or a baseline test.
Easy to get tested
Full assessment is complete in minutes
With the NeuroGlympse, testing is simple, requiring test subjects to place their head on a chin and forehead rest, and watch a video for less than four minutes. There are no literacy or language fluency requirements or even an ability to follow directions other than to watch TV.